Fabtech Technologies Limited (NSE:FABTECH)
India · Delayed Price · Currency is INR 147.02
-0.40 (-0.27%)
At close: Sep 11, 2026
Fabtech Technologies Revenue
Fabtech Technologies had revenue of 749.84M INR in the quarter ending June 30, 2026, with 10.26% growth. This brings the company's revenue in the last twelve months to 4.18B, up 14.16% year-over-year. In the fiscal year ending March 31, 2026, Fabtech Technologies had annual revenue of 4.11B with 25.75% growth.
Revenue (ttm)
4.18B
Revenue Growth
+14.16%
P/S Ratio
1.56
Revenue / Employee
22.46M
Employees
186
Market Cap
6.54B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.11B | 841.03M | 25.75% |
| Mar 31, 2025 | 3.27B | 1.01B | 44.46% |
| Mar 31, 2024 | 2.26B | 323.39M | 16.69% |
| Mar 31, 2023 | 1.94B | -633.82M | -24.65% |
| Mar 31, 2022 | 2.57B | 1.36B | 112.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Lenskart Solutions | 96.34B |
| Haleos Labs | 3.24B |
| Valiant Laboratories | 3.06B |
| Amanta Healthcare | 2.91B |
| Max India | 2.39B |